Icagen Inc., of Research Triangle Park, N.C., added Richard Katz as senior vice president finance and corporate development and chief financial officer.
IDEC Pharmaceuticals Corp., of San Diego, promoted Edward Rodriguez to vice president, finance and controller.
ImmuCell Corp., of Portland, Maine, elected Joseph Crabb, Jonathan Rothschild and Tracy Wilkins to its board.
InforMax Inc., of Bethesda, Md., promoted Stephen Lincoln to executive vice president, product development and chief scientific officer.
La Jolla Pharmaceutical Co., of San Diego, appointed William Welch vice president of marketing.
LigoCyte Pharmaceuticals Inc., of Bozeman, Mont., elected Kathleen McKereghan to its board.
Lorus Therapeutics Inc., of Toronto, appointed Alan Steigrod and Graham Strachan to its board.
MDS Proteomics, of Toronto, a subsidiary of MDS Inc., appointed Frank Lee to its board.
MGI Pharma Inc., of Minneapolis, elected Philip Schein and David Sharrock to its board.
MPB Cologne GmbH, of Cologne, Germany, appointed Dirk Aikes chief financial officer and Sabine Hantke research director, plant biology.
Nastech Pharmaceutical Co. Inc., of Hauppauge, New York, added David Wormuth as senior vice president.
NuTec Sciences Inc., of Atlanta, added Anthony Shuker as president of the Life Sciences Division.
Oasis Biosciences Inc., of San Diego, appointed Frank-Roman Lauter and Randall Woods to its board.
OmniScience Pharmaceuticals Inc., of Tempe, Ariz., added Duncan Hill as vice president, business development.
PowderJect Pharmaceuticals plc, of Oxford, England, appointed Gerald Mvller deputy chairman.
Salix Pharmaceuticals Ltd., of Raleigh, N.C., named Joseph Tyler vice president, operations.
Senomyx Inc., of La Jolla, Calif., appointed Saiid Zarrabian president and chief operating officer.
Sicor Inc., of Irvine, Calif., elected Lee Burg to its board.
SignalGene Inc., of Montreal, appointed Claude Monette senior vice president and chief financial officer.
Silicon Genetics Inc., of Redwood City, Calif., added Saeid Akhtari as senior vice president and chief operating officer.
Targeted Genetics Corp., of Seattle, established a medical and scientific advisory board for its majority-owned subsidiary, CellExSys Inc. Members are: Lewellys Barker, Malcolm Brenner, Nathaniel Brown, Peter Doherty, Louis Picker, Mickey Urdea, Bruce Walker and Kim Clary.
UroGenesys Inc., of Santa Monica, Calif., named Aya Jakobovits senior vice president, technology and corporate development, and added Paul Kanan as vice president of operations and chief financial officer.